| CAS No. | 159351-69-6 |
|---|---|
| MDL No. | N/A |
| MF | C53H83NO14 |
| MW | 958.20 |
| InChI Key | HKVAMNSJSFKALM-GKUWKFKPSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 98% | $73 | In Stock | |
| 100 mg | 98% | $108 | In Stock | |
| 250 mg | 98% | $204 | In Stock | |
| 1 g | 98% | $603 | In Stock | |
| 5 g | 98% | $1773 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Everolimus is a macrocyclic lactone derived from rapamycin, where the hydroxy group on the cyclohexyl moiety is replaced by a 2-hydroxyethyl ether. It functions as an immunosuppressant, antineoplastic agent, mTOR inhibitor, anticoronaviral agent, and geroprotector. It is classified as a primary alcohol, secondary alcohol, ether, cyclic ketone, cyclic acetal, and macrolide lactam, and is functionally related to sirolimus.
| CAS No. | 159351-69-6 |
|---|---|
| Product Name | Everolimus |
Health Hazard
